Who owns Sarepta Therapeutics, Inc. (AVII)? Elite investor 13F holders
5 tracked elite investors reported holding Sarepta Therapeutics, Inc as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Oaktree Capital Management, Bridgewater Associates, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 20151163.00 USD | 1121378.000000 | Shares | reduce | Original filing |
| D.E. Shaw | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 15935532.00 USD | 16897000.000000 | Principal | hold | Original filing |
| D.E. Shaw | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Oaktree Capital Management | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 6344687.00 USD | 6709000.000000 | Principal | buy | Original filing |
| Bridgewater Associates | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2732662.00 USD | 152068.000000 | Shares | add | Original filing |
| Gotham Asset Management | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Ancora Advisors / Ancora Holdings | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 44925.00 USD | 2500.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.